Skip to content

COMPARISON OF CONTINUOUS AND INTERMITTENT PHOTOTHERAPY IN HEALTHY TERM NEONATES WITH HYPERBILIRUBINEMIA

COMPARISON OF EFFECTIVENESS OF CONTINUOUS AND INTERMITTENT PHOTOTHERAPY ON HEALTHY TERM NEONATES WITH HYPERBILIRUBINEMIA - A RANDOMISED CONTROL TRIAL - RCT

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059205
Enrollment
300
Registered
2023-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P599- Neonatal jaundice, unspecified Health Condition 2: P84- Other problems with newborn

Interventions

Intervention1: Intermittent Phototherapy: Continuous vs. 3 hours on and 3 hours off phototherapy Control Intervention1: Continuous phototherapy: 3 hours on and 3 hours off cycles of phototherapy

Sponsors

Uttar Pradesh University of Medical Sciences Saifai Etawah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Babies whose bilirubin level is above the range of pathological hyperbilirubinemia as per American academy of pediatrics nomogram irrespective of cause of hyperbilirubinemia. Term babies who have weight above 2.5kg. Babies less than 7days of life. Both male and female babies are included.

Exclusion criteria

Exclusion criteria: Parents who are not giving consent for the study. Babies who are having low birth weight and sick babies All term neonates with unstable vitals. Neonates admitted after 7th day of birth. Babies who are having congenital abnormalities. Babies whose total serum bilirubin falling in the exchange transfusion range at the time of admission, requiring NICU admission for any reason other than jaundice. Babies with direct bilirubin >20% of total bilirubin or direct bilirubin >2.0mg/dl Babies who have received prior phototherapy.

Design outcomes

Primary

MeasureTime frame
Rate of fall of bilirubin in term neonatesTimepoint: After stopping the phototherapy

Secondary

MeasureTime frame
Hospital stay and rebound hyperbilirubinemiaTimepoint: After stopping the phototherapy

Countries

India

Contacts

Public ContactDR DURGESH KUMAR

Uttar Pradesh University of Medical Sciences, Saifai, Etawah

drdurgeshk@gmail.com9917144512

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026